• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同病因肾病患者在蛋白质限制饮食情况下肾衰竭的进展。

Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet.

作者信息

Oldrizzi L, Rugiu C, Valvo E, Lupo A, Loschiavo C, Gammaro L, Tessitore N, Fabris A, Panzetta G, Maschio G

出版信息

Kidney Int. 1985 Mar;27(3):553-7. doi: 10.1038/ki.1985.46.

DOI:10.1038/ki.1985.46
PMID:3999543
Abstract

The rate of progression of early renal failure was evaluated in three groups of adult patients with renal disease of diverse etiology on dietary protein and phosphorus restriction (about 0.6 g/kg of protein, 700 mg of phosphorus) and in a control group of 22 patients with the same renal disease, retrospectively studied, on a free diet. Group 1 had 33 patients with chronic glomerulonephritis (CG), initial serum creatinine (Scr) of 1.4 to 4.3 mg/dl (mean, 2.20), followed for 5 to 94 months (mean, 44). Group 2 had 17 patients with polycystic kidney disease (PKD), Scr 1.3 to 4.7 mg/dl (mean, 2.40), followed for 8 to 81 months (mean, 42). Group 3 had 28 patients with primary chronic pyelonephritis (CP), Scr of 1.5 to 4.5 mg/dl (mean, 2.57), followed for 9 to 92 months (mean, 41). The control group had 22 patients (11 with CG, five with PKD, and six with CP), with Scr 1.7 to 4.1 mg/dl, followed for 6 to 72 months (mean, 24). In the regression analysis between reciprocal creatinine and time, the slopes were -0.0017, -0.0025, and -0.00016 dl/mg/month in the three patient groups on a protein-restricted diet, respectively. The difference between both groups 1 and 2 and group 3 was statistically significant (P less than 0.05). The slopes in patients on a free diet were significantly greater than those found in patients on a protein-restricted diet. The actuarial survival probability at 72 months, assuming as "renal death" a Scr of 10 mg/dl, was 45% in patients with CG, 44% in those with PKD, and 67% in those with CP on a protein-restricted diet.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对三组病因各异的成年肾病患者进行饮食蛋白质和磷限制(约0.6克/千克蛋白质,700毫克磷),并与22名患有相同肾病的对照组患者(回顾性研究,自由饮食)比较早期肾衰竭的进展情况。第一组有33例慢性肾小球肾炎(CG)患者,初始血清肌酐(Scr)为1.4至4.3毫克/分升(平均2.20),随访5至94个月(平均44个月)。第二组有17例多囊肾病(PKD)患者,Scr为1.3至4.7毫克/分升(平均2.40),随访8至81个月(平均42个月)。第三组有28例原发性慢性肾盂肾炎(CP)患者,Scr为1.5至4.5毫克/分升(平均2.57),随访9至92个月(平均41个月)。对照组有22例患者(11例CG,5例PKD,6例CP),Scr为1.7至4.1毫克/分升,随访6至72个月(平均24个月)。在肌酐倒数与时间的回归分析中,三组蛋白质限制饮食患者的斜率分别为-0.0017、-0.0025和-0.00016分升/毫克/月。第一组和第二组与第三组之间的差异具有统计学意义(P小于0.05)。自由饮食患者的斜率明显大于蛋白质限制饮食患者。假设Scr为10毫克/分升为“肾死亡”,72个月时CG患者的精算生存概率为45%,PKD患者为44%,CP患者蛋白质限制饮食时为67%。(摘要截断于250字)

相似文献

1
Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet.不同病因肾病患者在蛋白质限制饮食情况下肾衰竭的进展。
Kidney Int. 1985 Mar;27(3):553-7. doi: 10.1038/ki.1985.46.
2
Role of hypertension on the progression of renal disease in man.
Blood Purif. 1988;6(4):250-7. doi: 10.1159/000169551.
3
Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure.早期饮食中蛋白质和磷的限制对延缓慢性肾衰竭的进展有效。
Kidney Int Suppl. 1983 Dec;16:S273-7.
4
Effects of dietary protein and phosphorus restriction on the progression of early renal failure.
Kidney Int. 1982 Oct;22(4):371-6. doi: 10.1038/ki.1982.184.
5
Low-protein diet supplemented by keto acids in chronic renal failure: a prospective controlled study.慢性肾衰竭患者采用酮酸补充的低蛋白饮食:一项前瞻性对照研究。
Kidney Int Suppl. 1983 Dec;16:S263-7.
6
Does a low protein diet really slow down the rate of progression of chronic renal failure?低蛋白饮食真的能减缓慢性肾衰竭的进展速度吗?
Blood Purif. 1989;7(1):33-8. doi: 10.1159/000169571.
7
[Effect of low-protein diet on the control of progression of chronic renal failure].低蛋白饮食对慢性肾衰竭进展控制的影响
Pol Arch Med Wewn. 1988 Feb;79(2):63-74.
8
Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial.饮食蛋白质和磷限制未能延缓慢性肾衰竭的进展速度:一项前瞻性、随机、对照试验。
Q J Med. 1991 Oct;81(294):837-55.
9
Protein intake of more than 0.5 g/kg BW/day is not effective in suppressing the progression of chronic renal failure.每日蛋白质摄入量超过0.5克/千克体重对抑制慢性肾衰竭进展无效。
Contrib Nephrol. 2007;155:40-49. doi: 10.1159/000100995.
10
Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group.蛋白质限制对慢性肾功能不全进展影响的前瞻性、随机、多中心试验。意大利北部合作研究组。
Lancet. 1991 Jun 1;337(8753):1299-304. doi: 10.1016/0140-6736(91)92977-a.

引用本文的文献

1
The congenital and acquired solitary kidney.先天性及后天性孤立肾
Rev Urol. 2003 Winter;5(1):2-8.
2
Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome.溶血尿毒综合征后遗症患者的两种不同治疗方案。
Pediatr Nephrol. 2004 Oct;19(10):1148-52. doi: 10.1007/s00467-004-1516-y. Epub 2004 Jun 18.
3
Predictive factors of progression of chronic renal insufficiency: a multivariate analysis.
Pediatr Nephrol. 2003 Apr;18(4):371-7. doi: 10.1007/s00467-003-1115-3. Epub 2003 Mar 21.
4
Dietary treatment of renal insufficiency.肾功能不全的饮食治疗。
Arch Dis Child. 1993 Dec;69(6):704-8. doi: 10.1136/adc.69.6.704.
5
Choosing the right ACE inhibitor. A guide to selection.选择合适的血管紧张素转换酶抑制剂。选择指南。
Drugs. 1995 Apr;49(4):516-35. doi: 10.2165/00003495-199549040-00003.
6
[Drug treatment of chronic glomerulonephritis: contra].
Klin Wochenschr. 1985 Sep 16;63(18):978-87. doi: 10.1007/BF01738153.
7
[Drug treatment of chronic glomerulonephritis: pro].[慢性肾小球肾炎的药物治疗:支持观点]
Klin Wochenschr. 1985 Sep 16;63(18):967-77. doi: 10.1007/BF01738152.
8
Management of progressive renal failure: the role of dietary manipulations.进行性肾衰竭的管理:饮食调控的作用。
Postgrad Med J. 1987 Aug;63(742):611-5. doi: 10.1136/pgmj.63.742.611.
9
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.转换酶抑制剂在阻止大鼠系统性高血压相关的进行性肾脏疾病中的治疗优势。
J Clin Invest. 1986 Jun;77(6):1993-2000. doi: 10.1172/JCI112528.
10
Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.血管紧张素转换酶抑制剂对肾脏的影响:非糖尿病慢性肾病
Cardiovasc Drugs Ther. 1990 Feb;4(1):221-8. doi: 10.1007/BF01857636.